Patent · US Expired

Novel and improved antibodies for site specific attachment of compounds

US5047227A · kind A · utility

39Cited by
7References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 4, 1991
Grant dateSep 10, 1991
Priority date
Expiry dateFeb 4, 2011

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2123/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel and improved antibody compositions comprising an antibody or antibody fragment having an increased number of sites on a carbohydrate side chain available for the site specific attachment of a compound to a region of the antibody or antibody fragment which is not part of nor directly involved with the antigen binding site are disclosed. Conjugates, prepared using the high-mannose-containing antibodies, which are characterized by substantially the same immunospecificity as the unmodified unconjugated antibody molecule, are also disclosed. The antibody compositions are advantageously used for a wide variety of therapeutic and diagnostic applications in both in vivo and in vitro targeted delivery systems and assays. Methods for preparing the antibody compositions, as well as antibody conjugate intermediates, and methods for using the antibody compositions are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.